EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A guide to selecting high-performing renewable antibodies for KIF5A (Q12840) across western blot, immunoprecipitation, and immunofluorescence

Riham Ayoubi, Charles Alende iD, Maryam Fothouhi, Sara González Bolívar iD, Vincent Francis iD, Peter S McPherson, Carl Laflamme iD, NeuroSGC/YCharOS/EDDU collaborative group

F1000Research · 2026

DOI: 10.12688/f1000research.184178.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift F1000Research, 2026. Verfasst von Riham Ayoubi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Canada. Hauptthemen laut MEDLINE: Kinesins, Immunoprecipitation, Blotting, Western, Fluorescent Antibody Technique. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kinesin Family Member 5A (KIF5A) is an important protein for anterograde cellular transport. We characterized ten commercially available research antibodies against KIF5A for use in western blot, immunoprecipitation, and immunofluorescence using a standardized workflow. Antibody performance was assessed by comparing signal in a wild-type cell line and its corresponding knockout derivative. This work is part of a broader collaborative public-good initiative to improve biomedical research by systematically evaluating commercial antibodies against human proteins and openly sharing the data as a resource for the scientific community. We encourage readers to use this report as a guide for selecting antibodies best suited to their specific applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KinesinsImmunoprecipitationBlotting, WesternFluorescent Antibody TechniqueAntibodiesHumans

Stichwörter der Autor:innen

KIF5AKinesin Family Member 5AKinesin heavy chain isoform 5AUniProt ID Q12840antibody characterizationantibody validationimmunofluorescenceimmunoprecipitationwestern blot

Substanzen

KinesinsAntibodiesKIF5A protein, human

Autor:innen und Institutionen

  • Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Canada.

ORCID-Profile: Charles Alende, Sara González Bolívar, Vincent Francis, Carl Laflamme

Zitieren

APA

Ayoubi, R., Alende, C., Fothouhi, M., Bolívar, S. G., Francis, V., McPherson, P. S., Laflamme, C., & NeuroSGC/YCharOS/EDDU collaborative group (2026). A guide to selecting high-performing renewable antibodies for KIF5A (Q12840) across western blot, immunoprecipitation, and immunofluorescence. F1000Research. https://doi.org/10.12688/f1000research.184178.1

Vancouver

Ayoubi R, Alende C, Fothouhi M, Bolívar SG, Francis V, McPherson PS, et al. A guide to selecting high-performing renewable antibodies for KIF5A (Q12840) across western blot, immunoprecipitation, and immunofluorescence. F1000Research. 2026. doi:10.12688/f1000research.184178.1

BibTeX
@article{Ayoubi2026,
  author = {Ayoubi, Riham and Alende, Charles and Fothouhi, Maryam and Bolívar, Sara González and Francis, Vincent and McPherson, Peter S and Laflamme, Carl and NeuroSGC/YCharOS/EDDU collaborative group, NeuroSGC/YCharOS/EDDU collaborative group},
  title = {A guide to selecting high-performing renewable antibodies for KIF5A (Q12840) across western blot, immunoprecipitation, and immunofluorescence},
  journal = {F1000Research},
  year = {2026},
  doi = {10.12688/f1000research.184178.1}
}
Kostenlos starten →